Your session is about to expire
← Back to Search
RelieVRx for Opioid Use Disorder
Study Summary
This trial tests a VR device to help people w/ chronic pain & opioid addiction.
- Opioid Use Disorder
- Chronic Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research specifically looking for new participants?
"Affirmative. According to the information accessible on clinicaltrials.gov, this clinical trial is currently enrolling participants with an initial posting date of February 8th 2023 and a recent update taking place on February 9th 2023. 40 volunteers are required from 1 medical facility."
What are the major goals of this trial?
"The goal of this clinical trial, which will be monitored over the course of 6 weeks and beginning at baseline, is to measure Change in Pain Intensity. Secondary objectives include evaluating change in Pain Interference (measured with a Patient-Reported Outcomes Measurement Information System Pain Intensity Subscale), measuring Change in Fatigue (assessed by a Patient-Reported Outcomes Measurement Information Fatigue 4a Heal) and examining Changes in Social Function (via the use of the Patient-Reported Outcomes Measurement Information Ability to Participate Social 4a Heal)."
What is the current patient count for this clinical trial?
"Affirmative, the information on clinicaltrials.gov suggests that this trial is actively enrolling participants at present. The initial posting was made on 8th February 2023 and revised 9th February 2023. Forty individuals across one medical site are being sought after for the study."
Share this study with friends
Copy Link
Messenger